newsfilter
← Latest News
GlobeNewswire·

Tempest Reports First Quarter 2025 Financial Results and Provides Business Update

Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment of familial